Last 12 months
Inside the activity.
0 purchase rows · 13 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 0 |
| Dec 2025 | 0 | 0 |
| Jan 2026 | 0 | 0 |
| Feb 2026 | 0 | 0 |
| Mar 2026 | 0 | 0 |
| Apr 2026 | 0 | 0 |
| May 2026 | 0 | 0 |
| Jun 2026 | 0 | 0 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 0 | 13 |
| Sep 2026 | 0 | 0 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| August 17, 2026 Filed Aug 18, 2026 11:39 UTC |
Geva-Dvash OritVice President, HR
|
SaleOrdinary Shares | 508 | $175.00 | $88,900.00 |
DisclosureSEC source: 0001976408-26-000752 · primary_doc.xml · nonDerivative · entry 1 Geva-Dvash Orit · CIK 0001973444 · Vice President, HR 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 5,205 Read SEC document |
| August 14, 2026 Filed Aug 17, 2026 12:30 UTC |
Andorn Karni YarlDirector
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 3,176 | $0.00 Strike: $22.63 | $0.00 |
DisclosureSEC source: 0001976408-26-000745 · primary_doc.xml · derivative · entry 7 Andorn Karni Yarl · CIK 0001974306 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Ordinary Shares · 3,176 shares Expires 2029-11-10 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · kind: The options reported herein were exercised and the underlying shares were sold on the same date as reported in Table I. Read SEC document |
| August 14, 2026 Filed Aug 17, 2026 12:30 UTC |
Andorn Karni YarlDirector
|
SaleOrdinary Shares | 3,176 | $164.40 | $522,134.40 |
DisclosureSEC source: 0001976408-26-000745 · primary_doc.xml · nonDerivative · entry 5 Andorn Karni Yarl · CIK 0001974306 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,343 Read SEC document |
| August 14, 2026 Filed Aug 17, 2026 12:30 UTC |
Andorn Karni YarlDirector
|
Exercise / conversionOrdinary Shares | 3,176 | $22.63 | $71,872.88 |
DisclosureSEC source: 0001976408-26-000745 · primary_doc.xml · nonDerivative · entry 4 Andorn Karni Yarl · CIK 0001974306 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 4,519 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: The shares were acquired upon the exercise of stock options Read SEC document |
| August 13, 2026 Filed Aug 17, 2026 12:30 UTC |
Andorn Karni YarlDirector
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 880 | $0.00 Strike: $63.51 | $0.00 |
DisclosureSEC source: 0001976408-26-000745 · primary_doc.xml · derivative · entry 6 Andorn Karni Yarl · CIK 0001974306 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Ordinary Shares · 880 shares Expires 2030-12-21 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · kind: The options reported herein were exercised and the underlying shares were sold on the same date as reported in Table I. Read SEC document |
| August 13, 2026 Filed Aug 17, 2026 12:30 UTC |
Andorn Karni YarlDirector
|
SaleOrdinary Shares | 1,476 | $172.12 | $254,052.22 |
DisclosureSEC source: 0001976408-26-000745 · primary_doc.xml · nonDerivative · entry 3 Andorn Karni Yarl · CIK 0001974306 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,343 F2 · price: The price reported is a weighted average price. These shares were sold in multiple transactions ranging from $172.1094 to $172.1571. The reporting person undertakes to provide full information regarding the number of shares sold at each separate price upon request Read SEC document |
| August 13, 2026 Filed Aug 17, 2026 12:30 UTC |
Andorn Karni YarlDirector
|
SaleOrdinary Shares | 880 | $172.74 | $152,013.66 |
DisclosureSEC source: 0001976408-26-000745 · primary_doc.xml · nonDerivative · entry 2 Andorn Karni Yarl · CIK 0001974306 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,819 Read SEC document |
| August 13, 2026 Filed Aug 17, 2026 12:30 UTC |
Andorn Karni YarlDirector
|
Exercise / conversionOrdinary Shares | 880 | $63.51 | $55,888.80 |
DisclosureSEC source: 0001976408-26-000745 · primary_doc.xml · nonDerivative · entry 1 Andorn Karni Yarl · CIK 0001974306 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 3,699 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: The shares were acquired upon the exercise of stock options Read SEC document |
| August 13, 2026 Filed Aug 17, 2026 11:58 UTC |
Langer RamChief Operating Officer
|
SaleOrdinary Shares | 6,387 | $172.32 | $1,100,621.89 |
DisclosureSEC source: 0001976408-26-000744 · primary_doc.xml · nonDerivative · entry 1 Langer Ram · CIK 0001973443 · Chief Operating Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 17,532 F1 · price: The price reported is a weighted average price. These shares were sold in multiple transactions ranging from $172.13 to $172.72. The reporting person undertakes to provide full information regarding the number of shares sold at each separate price upon request Read SEC document |
| August 13, 2026 Filed Aug 17, 2026 11:57 UTC |
AMIT RAFIChief Executive Officer
|
SaleOrdinary Shares | 6,250 | $170.52 | $1,065,750.00 |
DisclosureSEC source: 0001976408-26-000743 · primary_doc.xml · nonDerivative · entry 1 AMIT RAFI · CIK 0001135131 · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 55,350 Read SEC document |
| August 12, 2026 Filed Aug 13, 2026 14:56 UTC |
Geva-Dvash OritVice President, HR
|
SaleOrdinary Shares | 415 | $174.06 | $72,235.85 |
DisclosureSEC source: 0001976408-26-000731 · primary_doc.xml · nonDerivative · entry 1 Geva-Dvash Orit · CIK 0001973444 · Vice President, HR 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 5,713 F1 · balance_after: The reported balance includes one additional share that was inadvertently omitted from the reporting person's Form 3 due to a rounding error. Read SEC document |
| August 12, 2026 Filed Aug 13, 2026 14:41 UTC |
Aviram LiorDirector
|
SaleOrdinary Shares | 1,681 | $175.00 | $294,175.00 |
DisclosureSEC source: 0001976408-26-000730 · primary_doc.xml · nonDerivative · entry 4 Aviram Lior · CIK 0002097816 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 12,518 Read SEC document |
| August 12, 2026 Filed Aug 13, 2026 14:41 UTC |
Aviram LiorDirector
|
SaleOrdinary Shares | 1,666 | $172.73 | $287,768.18 |
DisclosureSEC source: 0001976408-26-000730 · primary_doc.xml · nonDerivative · entry 3 Aviram Lior · CIK 0002097816 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 14,199 Read SEC document |
| August 12, 2026 Filed Aug 13, 2026 14:41 UTC |
Eisenberg MosheChief Financial Officer
|
SaleOrdinary Shares | 645 | $172.67 | $111,373.25 |
DisclosureSEC source: 0001976408-26-000729 · primary_doc.xml · nonDerivative · entry 2 Eisenberg Moshe · CIK 0001972379 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 16,239 Read SEC document |
| August 11, 2026 Filed Aug 13, 2026 14:41 UTC |
Aviram LiorDirector
|
SaleOrdinary Shares | 1,689 | $162.00 | $273,618.00 |
DisclosureSEC source: 0001976408-26-000730 · primary_doc.xml · nonDerivative · entry 2 Aviram Lior · CIK 0002097816 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 15,865 Read SEC document |
| August 11, 2026 Filed Aug 13, 2026 14:41 UTC |
Aviram LiorDirector
|
SaleOrdinary Shares | 1,658 | $164.00 | $271,912.00 |
DisclosureSEC source: 0001976408-26-000730 · primary_doc.xml · nonDerivative · entry 1 Aviram Lior · CIK 0002097816 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 17,554 F1 · balance_after: The reported balance includes one additional share that was inadvertently omitted from the reporting person's Form 3 due to a rounding error. Read SEC document |
| August 11, 2026 Filed Aug 13, 2026 14:41 UTC |
Eisenberg MosheChief Financial Officer
|
SaleOrdinary Shares | 3,759 | $160.06 | $601,650.88 |
DisclosureSEC source: 0001976408-26-000729 · primary_doc.xml · nonDerivative · entry 1 Eisenberg Moshe · CIK 0001972379 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 16,884 F1 · price: The price reported is a weighted average price. These shares were sold in multiple transactions ranging from $160.00 to $160.5651. The reporting person undertakes to provide full information regarding the number of shares sold at each separate price upon request Read SEC document |
| July 29, 2026 Filed Jul 30, 2026 15:48 UTC |
Shacham YosefDirector
|
GrantStock Option (Right to Buy) · Derivative | 571 | $0.00 Strike: $147.87 | $0.00 |
DisclosureSEC source: 0001976408-26-000681 · primary_doc.xml · derivative · entry 2 Shacham Yosef · CIK 0001973440 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 571 Underlying: Ordinary Shares · 571 shares Expires 2033-07-29 F2 · kind: The Reporting Person was granted stock options to purchase ordinary shares of Camtek Ltd (the "Company") subject to the Reporting Person's continued service through such vesting date. F3 · derivative.exercise_date: The options will vest on the date of the Company's 2027 annual meeting of shareholders, subject to continued service through the vesting date. Read SEC document |
| July 29, 2026 Filed Jul 30, 2026 15:48 UTC |
Shacham YosefDirector
|
GrantOrdinary Shares | 254 | $0.00 | $0.00 |
DisclosureSEC source: 0001976408-26-000681 · primary_doc.xml · nonDerivative · entry 1 Shacham Yosef · CIK 0001973440 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 6,734 F1 · kind: The restricted stock units ("RSUs") reported herein represent a contingent right to receive one share of ordinary stock of Camtek Ltd (the "Company"). All 254 RSUs reported hereby will vest on the date of the Company's 2027 annual meeting of shareholders, subject to the Reporting Person's continued service through such vesting date. Read SEC document |
| July 29, 2026 Filed Jul 30, 2026 15:48 UTC |
Andorn Karni YarlDirector
|
GrantStock Option (Right to Buy) · Derivative | 571 | $0.00 Strike: $147.87 | $0.00 |
DisclosureSEC source: 0001976408-26-000680 · primary_doc.xml · derivative · entry 2 Andorn Karni Yarl · CIK 0001974306 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 571 Underlying: Ordinary Shares · 571 shares Expires 2033-07-29 F2 · kind: The Reporting Person was granted stock options to purchase ordinary shares of Camtek Ltd (the "Company") subject to the Reporting Person's continued service through such vesting date. F3 · derivative.exercise_date: The options will vest on the date of the Company's 2027 annual meeting of shareholders, subject to continued service through the vesting date. Read SEC document |
| July 29, 2026 Filed Jul 30, 2026 15:48 UTC |
Andorn Karni YarlDirector
|
GrantOrdinary Shares | 254 | $0.00 | $0.00 |
DisclosureSEC source: 0001976408-26-000680 · primary_doc.xml · nonDerivative · entry 1 Andorn Karni Yarl · CIK 0001974306 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,819 F1 · kind: The restricted stock units ("RSUs") reported herein represent a contingent right to receive one share of ordinary stock of Camtek Ltd (the "Company"). All 254 RSUs reported hereby will vest on the date of the Company's 2027 annual meeting of shareholders, subject to the Reporting Person's continued service through such vesting date. Read SEC document |
| July 29, 2026 Filed Jul 30, 2026 15:48 UTC |
Stav OritDirector
|
GrantStock Option (Right to Buy) · Derivative | 571 | $0.00 Strike: $147.87 | $0.00 |
DisclosureSEC source: 0001976408-26-000679 · primary_doc.xml · derivative · entry 2 Stav Orit · CIK 0001965230 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 571 Underlying: Ordinary Shares · 571 shares Expires 2033-07-29 F2 · kind: The Reporting Person was granted stock options to purchase ordinary shares of Camtek Ltd (the "Company") subject to the Reporting Person's continued service through such vesting date. F3 · derivative.exercise_date: The options will vest on the date of the Company's 2027 annual meeting of shareholders, subject to continued service through the vesting date. Read SEC document |
| July 29, 2026 Filed Jul 30, 2026 15:48 UTC |
Stav OritDirector
|
GrantOrdinary Shares | 254 | $0.00 | $0.00 |
DisclosureSEC source: 0001976408-26-000679 · primary_doc.xml · nonDerivative · entry 1 Stav Orit · CIK 0001965230 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,819 F1 · kind: The restricted stock units ("RSUs") reported herein represent a contingent right to receive one share of ordinary stock of Camtek Ltd (the "Company"). All 254 RSUs reported hereby will vest on the date of the Company's 2027 annual meeting of shareholders, subject to the Reporting Person's continued service through such vesting date. Read SEC document |
| July 29, 2026 Filed Jul 30, 2026 15:46 UTC |
Ben Arie MordechayDirector
|
GrantStock Option (Right to Buy) · Derivative | 571 | $0.00 Strike: $147.87 | $0.00 |
DisclosureSEC source: 0001976408-26-000678 · primary_doc.xml · derivative · entry 2 Ben Arie Mordechay · CIK 0001973441 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 571 Underlying: Ordinary Shares · 571 shares Expires 2033-07-29 F2 · kind: The Reporting Person was granted stock options to purchase ordinary shares of Camtek Ltd (the "Company") subject to the Reporting Person's continued service through such vesting date. F3 · derivative.exercise_date: The options will vest on the date of the Company's 2027 annual meeting of shareholders, subject to continued service through the vesting date. Read SEC document |
| July 29, 2026 Filed Jul 30, 2026 15:46 UTC |
Ben Arie MordechayDirector
|
GrantOrdinary Shares | 254 | $0.00 | $0.00 |
DisclosureSEC source: 0001976408-26-000678 · primary_doc.xml · nonDerivative · entry 1 Ben Arie Mordechay · CIK 0001973441 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,891 F1 · kind: The restricted stock units ("RSUs") reported herein represent a contingent right to receive one share of ordinary stock of Camtek Ltd (the "Company"). All 254 RSUs reported hereby will vest on the date of the Company's 2027 annual meeting of shareholders, subject to the Reporting Person's continued service through such vesting date. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.